Chris Buyse

Chris Buyse

Direktor/Vorstandsmitglied bei INVENTIVA

Vermögen: - $ am 31.05.2024

59 Jahre
Health Technology
Finance
Commercial Services

Ursprung des Netzwerks ersten Grades von Chris Buyse

EinheitArt der EinheitIndustrie
Extinct Pharmaceuticals: Major 21
Public Company Biotechnology 21
Public Company Pharmaceuticals: Major 17
15
Subsidiary Biotechnology 15
Public Company Biotechnology 14
University of Antwerp
12
College/University Other Consumer Services 12
Public Company Pharmaceuticals: Major 11
8
Holding Company Medical Specialties 8
7
Private Company Investment Managers 7
5
Holding Company Biotechnology 5
5
Private Company Real Estate Development 5
Public Company Packaged Software 4
Pinnacle Investments NV
3
Private Company 3
Fondation Francqui
2
Private Company 2
2
Private Company Miscellaneous Commercial Services 2
2
Private Company Wireless Telecommunications 2
2
Non-Profit Organization Investment Trusts/Mutual Funds 2
1
Private Company Miscellaneous Commercial Services 1
Public Company Biotechnology 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Chris Buyse

UnternehmenSektorVerknüpfte PersonenHauptposition
Université Catholique de Louvain College/University

Johan Cardoen

Nicolas Jacques Boël

Baron Jean Stéphenne

Marc Nolet de Brauwere

Jan Delcour

Decebal Bora

Etienne Marc Sokal

Paul Deleu

Michael P. Cooreman

Doctorate Degree

Undergraduate Degree

Chairman

Graduate Degree

Corporate Officer/Principal

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

Katholieke Universiteit Leuven College/University

Marc Nolet de Brauwere

Désiré Collen

Staf van Reet

Patrik de Haes

Wim Goemaere

Stéphane Vandervelde

Patricia Ceysens

Alexandra Tolia

Johan Bohets

Graduate Degree

Doctorate Degree

Doctorate Degree

Doctorate Degree

Graduate Degree

Undergraduate Degree

Graduate Degree

Doctorate Degree

Graduate Degree

College/University

Johan Cardoen

Staf van Reet

Emil Pot

Lothar Steidler

Wim Goemaere

Pieter Rottiers

Chief Executive Officer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

Electronic Equipment/Instruments

Leon van Rompay

Stijn van Rompay

Baron Jean Stéphenne

Stefan Yee

Marc Foidart

Director/Board Member

Chief Executive Officer

Director/Board Member

Director/Board Member

Director/Board Member

Ghent University College/University

Magda van Hijfte

Sabine Neirynck

Lothar Steidler

Pieter Rottiers

Andy de Deene

Graduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

Université Libre de Bruxelles College/University

Jos Sluys

Françoise Masai

Cécile Galle

Alexandra Tolia

Undergraduate Degree

Graduate Degree

Corporate Officer/Principal

Undergraduate Degree

Pharmaceuticals: Major

Frédéric Cren

Pierre Broqua

Jean Volatier

Nathalie Harroy

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Patrick van Beneden

Johan Cardoen

Staf van Reet

Patrik de Haes

Director/Board Member

Chairman

Chairman

Chairman

Solvay Business School of Economics & Management College/University

Stefan Yee

Alexandra Tolia

Johan Bohets

Thomas Lienard

Masters Business Admin

Undergraduate Degree

Graduate Degree

Graduate Degree

Pharmaceuticals: Major

Frédéric Cren

Pierre Broqua

Nathalie Harroy

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Human Resources Officer

TIGENIX NV Medical Specialties

Baron Jean Stéphenne

Claudia D'Augusta

Mounia Chaoui-Roulleau

Chairman

Director of Finance/CFO

Director/Board Member

Miscellaneous Commercial Services

Patrick van Beneden

Johan Cardoen

Magda van Hijfte

Director/Board Member

President

Director of Finance/CFO

Pharmaceuticals: Major

Leon van Rompay

Stijn van Rompay

Stefan Yee

Founder

Chief Executive Officer

Director/Board Member

Biotechnology

Stijn van Rompay

Stefan Yee

Marc Foidart

Director/Board Member

Director/Board Member

Director/Board Member

Investment Managers

Marc Foidart

Benoit Fellin

Eric Brandt

Private Equity Investor

Private Equity Investor

Private Equity Investor

BNP PARIBAS FORTIS SA Major Banks

Baron Jean Stéphenne

Koenraad van der Elst

Director/Board Member

General Counsel

Pharmaceuticals: Major

Stijn van Rompay

Thomas Jacobsen

Chief Executive Officer

Director/Board Member

Pharmaceuticals: Major

Stijn van Rompay

Thomas Jacobsen

Founder

Founder

GOLDEN QUEEN MINING CONSOLIDATED LTD. Precious Metals

Landon Clay

Thomas Moragne Clay

Director/Board Member

Chief Executive Officer

Pharmaceuticals: Major

Johan Cardoen

Alexandra Tolia

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Marc Nolet de Brauwere

Benoit Fellin

Director/Board Member

Director/Board Member

MITHRA PHARMACEUTICALS S.A. Pharmaceuticals: Major

Leon van Rompay

Marc Foidart

Chief Executive Officer

Director/Board Member

Finance/Rental/Leasing

Guido René van der Schueren

Alain Hubert

Director/Board Member

Director/Board Member

Packaged Software

Guido René van der Schueren

Stéphane Vandervelde

Chief Executive Officer

Director/Board Member

Packaged Software

Guido René van der Schueren

Stéphane Vandervelde

Chairman

Director/Board Member

Packaged Software

Guido René van der Schueren

Stéphane Vandervelde

Chairman

Director/Board Member

Vlerick Leuven Gent Management School College/University

Jos Sluys

Andy de Deene

Masters Business Admin

Masters Business Admin

Magenta Tree BV

Marc Nolet de Brauwere

Thierry François

Corporate Officer/Principal

Founder

ESSEC Business School College/University

Annick Schwebig

Karen Pignet-Aiach

Chief Executive Officer

Undergraduate Degree

Investment Managers

Pierre de Waha

Thierry François

Private Equity Investor

Director/Board Member

North Dakota State University College/University

Jennifer Bath

Kari Graber

Doctorate Degree

Undergraduate Degree

Pharmaceuticals: Major

Frédéric Cren

Pierre Broqua

Corporate Officer/Principal

Corporate Officer/Principal

Université Paris Dauphine-PSL College/University

Frédéric Cren

Jean Volatier

Undergraduate Degree

Graduate Degree

Pharmaceuticals: Major

Michael P. Cooreman

Pierre Broqua

Corporate Officer/Principal

Corporate Officer/Principal

LYSOGENE Miscellaneous Commercial Services

Karen Pignet-Aiach

Philippe Pierre Goupit

Chief Executive Officer

Director/Board Member

DELHAIZE GROUP Food Retail

Jean-Luc Vandebroek

Denis Knoops

Corporate Officer/Principal

Chief Executive Officer

Pharmaceuticals: Major

Philippe Monteyne

Caroline Thielen

Director/Board Member

Director/Board Member

Biotechnology

Philippe Monteyne

Alexandra Tolia

Director/Board Member

Director/Board Member

Sise SA

Wim Goemaere

Jean-Luc Vandebroek

Director/Board Member

Director/Board Member

Vrije Universiteit Brussel College/University

Stefan Yee

Koenraad van der Elst

Graduate Degree

Corporate Officer/Principal

Pharmaceuticals: Generic

Claudia D'Augusta

Mounia Chaoui-Roulleau

Director of Finance/CFO

Director/Board Member

Miscellaneous Commercial Services

Damian Marron

Frédéric Cren

Director/Board Member

Director/Board Member

University College Cork College/University

Sabine Neirynck

Lothar Steidler

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Jean-Louis Abitbol

Damian Marron

Chief Tech/Sci/R&D Officer

Chief Executive Officer

Pharmaceuticals: Major

Patrik de Haes

Decebal Bora

Corporate Officer/Principal

General Counsel

INSEAD College/University

Patrik de Haes

Frédéric Cren

Undergraduate Degree

Masters Business Admin

Statistik

International

Belgien 30
Frankreich 13
Vereinigte Staaten 4
Kanada 3
Luxemburg 2

Sektoral

Health Technology 19
Consumer Services 16
Finance 6
Commercial Services 5
Technology Services 4

Operativ

Director/Board Member 457
Corporate Officer/Principal 147
Chairman 103
Chief Executive Officer 83
Independent Dir/Board Member 59
  1. Börse
  2. Insiders
  3. Chris Buyse
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT